Your browser doesn't support javascript.
loading
Intracellular Paclitaxel Delivery Facilitated by a Dual-Functional CPP with a Hydrophobic Hairpin Tail.
Wei, Yuping; Zhang, Man; Jiao, Pengfei; Zhang, Xin; Yang, Ganggang; Xu, Xia.
Afiliación
  • Wei Y; School of Life Science and Technology, Nanyang Normal University, Nanyang, Henan Province 473061, P.R. China.
  • Zhang M; State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P.R. China.
  • Jiao P; Department of Oncology, Nanyang First People's Hospital, Henan Province, 473002, P.R. China.
  • Zhang X; School of Life Science and Technology, Nanyang Normal University, Nanyang, Henan Province 473061, P.R. China.
  • Yang G; School of Life Science and Technology, Nanyang Normal University, Nanyang, Henan Province 473061, P.R. China.
  • Xu X; Biochemical Engineering Research Centre, Anhui University of Technology, Ma'anshan, Anhui Province 243032, P.R. China.
ACS Appl Mater Interfaces ; 13(4): 4853-4860, 2021 Feb 03.
Article en En | MEDLINE | ID: mdl-33474938
In our pervious study, a dual-functional peptide R7 was developed to form a complex with paclitaxel (PTX) for enhancement of PTX translocation. However, because of the unstable noncovalent bond between R7 and PTX, PTX redistributed after the introduction of heparin, leading to R7-PTX complex dissociation, further causing less PTX penetration than expected. Thus, a novel positive CPP carrier of P9 was developed to improve CPP-PTX affinity via a double-proline (Pro, P) hairpin tail and enhance PTX translocation through the reduction of translocation energy barrier, confirmed by the MM-PBSA analysis and umbrella sampling simulation. Cellular uptake study reveals that P9 can quickly translocate into the HeLa cells within 1 min and exhibits no noticeable cytotoxicity. Compared to R7, P9 is able to help PTX translocation, leading to a remarkable increase in the intracellular concentration of PTX, eventually resulting in a significant loss in tumor cell viability. In vivo experiments demonstrate that a vein injection of P9-PTX complex dramatically inhibits tumor growth. Our study provides a novel perspective for designing CPP-facilitated drug carrier to enhance antitumor efficiency.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Paclitaxel / Péptidos de Penetración Celular / Antineoplásicos Fitogénicos Límite: Humans Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Paclitaxel / Péptidos de Penetración Celular / Antineoplásicos Fitogénicos Límite: Humans Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos